The present invention features solid pharmaceutical compositions comprising Compound 1 (or a pharmaceutically acceptable salt thereof), Compound 2 (or a pharmaceutically acceptable salt thereof), and ritonavir (a pharmaceutically acceptable salt thereof), which are co-formulated in amorphous solid dispersion comprising a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant.Cette invention concerne des compositions pharmaceutiques solides comprenant un Composé 1 (ou un sel pharmaceutiquement acceptable de celui-ci) utiles dans le traitement du vih
